mario caccese

Istituto Oncologico Veneto

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Filippo Ceccato

Azienda Ospedale Università Padova

ITALY

View details

Riccardo Morganti

Chief, Doctor of Science, PhD

University Hospital of Pisa

ITALY

View details

Marzia ROSSATO

Associate Professor

University of Verona

ITALY

View details

Giuseppe Minniti

Sapienza University of Rome

ITALY

View details

giovanni donato aquaro

Assistant professor

University of Pisa

ITALY

View details

Antonella Brunello

Istituto Oncologico Veneto IOV-IRCCS

ITALY

View details

Alba Scerrati

Assistant Professor

University of Ferrara

ITALY

View details

Gian Luca De Salvo

Head

Istituto Oncologico Veneto IOV-IRCCS

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

mario caccese

Research Interests

Explore related searches

Contact this professor

Articles (12)

Glioblastoma and Internal Carotid Artery Calcium Score: A Possible Novel Prognostic Partnership?

REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

Antigen rapid diagnostic test monitoring for SARS‐CoV‐2 in asymptomatic and fully vaccinated cancer patients: Is it cost‐effective?

Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis

The role of radiation therapy and systemic treatments in meningioma: The present and the future

Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series

Metronomic Temozolomide in Heavily Pretreated Patients with Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: a Large Real-life Mono-institutional Study

Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care

Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology

PET/MR in recurrent glioblastoma patients treated with regorafenib: [<sup>18</sup>F]FET and DWI-ADC for response assessment and survival prediction

Advances in Multidisciplinary Management of Skull Base Meningiomas

A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib

Collaborators (8)

Filippo Ceccato

Riccardo Morganti

Marzia ROSSATO

Giuseppe Minniti

giovanni donato aquaro

Antonella Brunello

Alba Scerrati

Gian Luca De Salvo

Make your next move.